IONS - IONIS PHARMACEUTICALS INC
75.16
-4.290 -5.708%
Share volume: 2,969,717
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$79.45
-4.29
-0.05%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-01-2024 | 11-06-2024 | 02-19-2025 | 04-30-2025 | 07-30-2025 | 10-29-2025 | 02-26-2026 | |
| Assets | |||||||||
| Total Assets | 2.764 B | 2.691 B | 3.081 B | 3.004 B | 2.813 B | 2.985 B | 3.033 B | 3.524 B | |
| Current Assets | 2.416 B | 2.329 B | 2.714 B | 2.620 B | 2.419 B | 2.577 B | 2.519 B | 2.991 B | |
| Inventories | 30.259 M | 28.723 M | 28.452 M | 12.512 M | 11.502 M | 8.481 M | 10.470 M | 10.048 M | |
| Other Current Assets | 179.200 M | 221.974 M | 202.122 M | 310.122 M | 262.278 M | 226.109 M | 243.744 M | 237.092 M | |
| Short Term Investments | 1.857 B | 1.785 B | 2.149 B | 2.056 B | 1.881 B | 1.993 B | 1.902 B | 2.305 B | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 348.889 M | 293.993 M | 334.605 M | 242.077 M | 264.192 M | 297.304 M | 338.341 M | 372.260 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 72.795 M | 75.902 M | 82.502 M | 94.251 M | 102.925 M | 111.951 M | 106.117 M | 123.048 M | |
| Other Assets | 275.458 M | 285.843 M | 284.747 M | 289.134 M | 291.091 M | 296.032 M | 407.981 M | 410.153 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 2.764 B | 2.691 B | 3.081 B | 3.004 B | 2.813 B | 2.985 B | 3.033 B | 3.524 B | |
| Total liabilities | 2.467 B | 2.427 B | 2.419 B | 2.415 B | 2.337 B | 2.353 B | 2.415 B | 3.035 B | |
| Total current liabilities | 327.648 M | 306.162 M | 304.566 M | 309.318 M | 250.293 M | 897.236 M | 903.456 M | 781.567 M | |
| Accounts Payable | 13.082 M | 9.243 M | 9.052 M | 42.964 M | 17.456 M | 22.800 M | 14.326 M | 28.082 M | |
| Other liabilities | 566.872 M | 575.527 M | 579.837 M | 542.212 M | 591.812 M | 600.279 M | 573.967 M | 551.353 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 1.189 B | 1.191 B | 1.192 B | 1.245 B | 1.195 B | 566.420 M | 567.123 M | 1.347 B | |
| Other liabilities | 566.872 M | 575.527 M | 579.837 M | 542.212 M | 591.812 M | 600.279 M | 573.967 M | 551.353 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 296.515 M | 263.698 M | 662.468 M | 588.351 M | 475.726 M | 631.724 M | 617.967 M | 489.089 M | |
| Common stock | 2.270 B | 2.304 B | 2.832 B | 2.869 B | 2.901 B | 2.933 B | 3.046 B | 3.146 B | |
| Retained earnings | -1.939 B | -2.005 B | -2.145 B | -2.250 B | -2.397 B | -2.273 B | -2.402 B | -2.631 B |